Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796

Published:2024-03-20 Issue:6 Volume:16 Page:1211
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Casili Giovanna¹,Scuderi Sarah Adriana¹^ORCID,Lanza Marika¹,Filippone Alessia¹^ORCID,Mannino Deborah¹,Giuffrida Raffaella²^ORCID,Colarossi Cristina²^ORCID,Mare Marzia²,Capra Anna Paola¹^ORCID,De Gaetano Federica¹^ORCID,Portelli Marco³,Militi Angela¹,Cuzzocrea Salvatore¹^ORCID,Paterniti Irene¹,Esposito Emanuela¹^ORCID

Affiliation:

1. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres, 31, 98166 Messina, Italy

2. IOM Ricerca, Via Penninazzo 11, 95029 Viagrande Catania, Italy

3. Department of Biomedical and Dental Science, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 98125 Messina, Italy

Abstract

In the original publication [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2072-6694/16/6/1211/pdf

Reference1 articles.

1. Casili, G., Scuderi, S.A., Lanza, M., Filippone, A., Mannino, D., Giuffrida, R., Colarossi, C., Mare, M., Capra, A.P., and De Gaetano, F. (2023). Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers, 15.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP